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The Synthesis of Waltherione F and Its Analogues with Modifications at the 
2- and 3-Positions as Potential Antitrypanosomal Agents 
Victor Zdorichenko,[a] Romain Paumier,[a] Thomas Whitmarsh-Everiss,[a] Mark Roe[a] and Brian Cox*[a] 
Abstract: Chagas disease also know as American Trypanosomiasis (AT) is a 
tropical parasitic disease endemic in South America, is caused by 
Trypanosoma cruzi which is transmitted by the blood-sucking insect vectors 
called triatomine bugs. Quinoline alkaloids from the root extract of Waltheria 
indica are known to possess antitrypanosomal activity. Waltherione F 3, one of 
those alkaloids, was synthesised in 5 steps in 11% overall yield. We report 
here the first X-ray crystallographic confirmation of the structure of 
Waltherione F 3. A key step in the sequence utilised the Conrad-Limpach 
synthesis for the formation of the quinolin-4(1H)-one ring system. Our 
synthetic strategy was designed to enable the modification of the 2- and 3-
positions of the scaffold, allowing the generation of a diverse library of 
analogues to support our on-going medicinal chemistry program that is looking 
for new agents to tackle this devastating disease. 
Introduction 
Recently, Cretton et al  reported the isolation of waltherione F 3, 
a quinoline alkaloid, from the root extract of Waltheria indica,[1]  
along with waltheriones E – L (2 – 9) and 8-deoxoantidesmone 1 
and antidesmone 10; the latter two had already been described 
in the literature (Figure 1).[2] 
 
Figure 1. Alkaloids isolated from the dichloromethane extract of the roots of 
Waltheria indica. 
The authors investigated the potential antitrypanosomal 
properties of the alkaloids, with compounds demonstrating 
activity against Trypanosoma cruzi, a parasite responsible for 
American Trypanosomiasis (AT), also known as Chagas disease, 
which is endemic in South America. The compounds were 
shown to selectively inhibit growth with IC50 values between 0.02 
and 3.1 μM, which makes them a good starting point for a drug 
discovery program. 
The synthesis of the oxabicyclic core of two structurally diverse 
waltheriones C 11 and D 12 has also been reported.[3] 
 
 
Figure 2. Waltheriones C and D (11 – 12). 
Results and Discussion 
Here we report a total synthesis of waltherione F 3. The 
molecule is accessible by a variety of synthetic methods 
available to make quinolines.[4]  The key step in our strategy was 
the Conrad-Limpach synthesis of quinolin-4(1H)-ones which 
allowed the construction of the core, involving a reaction of an 
arylamine and a β-keto ester (Scheme 1).[5] 
 
Scheme 1. Retrosynthetic plan for the total synthesis of waltherione F 3 and 
its analogues. 
Traditionally solvents with very high boiling points are used for 
this reaction, because the substrate for the cyclisation must be 
in the high-energy imine-enol tautomer 13, and because the 
cyclisation into the hemiketal breaks the aromaticity of the 
phenyl ring (Scheme 2).[6] Alternatively, a ketene–imine 
intermediate formed via direct elimination of the corresponding 
alcohol (R’OH) from the imine ester is an alternative reaction 
pathway. The cyclisation of this intermediate would also require 
the breaking of aromaticity and necessitate the same high-
temperature solvents. Indeed, mineral oil and diphenyl ether are 
among the most used solvents. 
 
Scheme 2. Mechanism of Conrad-Limpach synthesis of 4-hydroxyquinolines/ 
quinolin-4(1H)-ones. 
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We set about designing a synthetic strategy around the Conrad-
Limpach cyclisation that could be used for the total synthesis of 
the natural product but also that would be applicable to the 
synthesis of muliple analogues with modifications at the 2- and 
3-positions to support our medicinal chemistry program. Our 
initial studies focused on the construction of the “core” of 
waltherione F 3 (Scheme 3) in order to investigate the 
manipulation of the 3-position. 
 
 
Scheme 3. Investigation of the 3-postion of waltherione F 3. 
Following the Conrad-Limpach reaction protocol, reaction of 2-
methoxyaniline 14 with methyl acetoacetate 15 afforded desired 
quinolone derivative 16. It is important to acknowledge that the 
Conrad-Limpach synthesis can yield two structurally different 
isomers. During the condensation of an aromatic amine with a β-
ketoester, the former can react either at a ketone or an ester 
group. If reaction happens at the ketone, the product is a 
quinolin-4(1H)-one; if the amine reacts at the ester, a quinolin-
2(1H)-one is afforded. This reaction is often named Knorr 
quinoline synthesis, after Ludwig Knorr who reported in 1886 
that modification of the reaction conditions yielded a quinolin-
2(1H)-one.[7] Specifically, the reaction of the aromatic amine with 
the ketone group of the β-ketoester is kinetically favoured while 
nucleophilic attack at the ester group is thermodynamically 
favourable (Scheme 4).[8] 
 
  
Scheme 4. Two possible products of the Conrad-Limpach synthesis. 
Treatment of 16 with N-bromosuccinimide afforded 3-bromo-8-
methoxy-2-methylquinolin-4(1H)-one 17. Subsequent reaction 
with sodium methoxide catalysed by copper (I) iodide afforded 
3,8-dimethoxy-2-methylquinolin-4(1H)-one 18. 
Having established that the 3-position could be easily modified 
post cyclisation, the total synthesis of waltherione F 3 was 
initiated. Commercially available 4-methoxy-3-nitrobenzaldehyde 
19 was converted to 2-methoxy-5-octylaniline 22 via a Wittig 
reaction and subsequent hydrogenation, followed by cyclisation, 
afforded key intermediate 8-Methoxy-2-methyl-5-octylquinolin-
4(1H)-one 23 (Scheme 5). Finally, bromination and 
methoxylation afforded the desired product in 11% overall yield. 
 
Scheme 5. Waltherione F 3 synthesis. 
Structures of 23 and waltherione F 3 were confirmed by X-ray 
crystallography (Figure 3). 
 
 
Figure 3. X-ray crystallography of 23 [left] and waltherione F 3 [right]. 
Having successfully synthesised waltherione F 3, we turned our 
attention to the synthesis of analogues. A two-dimensional array 
of compounds was prepared varying the 2-position by the choice 
of β-keto ester in the Conrad-Limpach synthesis and varying the 
3-position with the application of a number of different 
methodologies (Figure 4). 
 
 
Figure 4. Analogues of waltherione F 3 chosen for synthesis. 
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Using the conditions for quinolin-4(1H)-one synthesis previously 
described in scheme 5, a series of β-keto esters were submitted 
for reaction with aniline 22 (Table 1). 
Table 1. Attempted Conrad-Limpach syntheses of quinolin-4(1H)-ones 25 – 30 
with reaction conditions for the first step of enamine formation and final 
cyclised product yield.  
 
Product R1 R2 Conditions for the 
intermediate enamine 
formation 
Cyclised product 
yield (%) 
25 Ethyl Et DCM, 16 h, 30 °C 52 
26 Isopropyl Et DCM, 48 h, reflux 12 
27 Methoxymethyl Me DCM, 36 h, reflux 48 
 
28 
 
n-Butyl 
Me DCM, 18 h, reflux Mixture 
Me n-Hexane, 24 h, reflux 56 
29 Cyclopropyl Et DCM, > 18 h, reflux 0 
30 Phenyl Et DCM, > 18 h, reflux 0 
 
 
Cyclisation yields of compounds 25, 27, 28 were found to be 
moderate, ranging from 48% to 56%. Intermediate enamine 
formation proceeded very slow at room temperature, therefore 
reflux was performed in majority of the reactions. Slow rate and 
poor yields could perhaps be attributed to steric effects, further 
supported by the unsuccessful reactions of cyclopropyl and 
phenyl β-keto ester derivatives for which no evidence of 
enamine formation was observed after the stated reaction times. 
The crude intermediates were submitted for the cyclisation step 
in diphenyl ether but products 29, 30 were not obtained, only 
aniline 22 starting material was recovered. 
The total synthesis of waltherione F 3 utilised N-
bromosuccinimide (NBS) reagent to selectively brominate the 
quinolin-4(1H)-one core at 3-position. With the aim of improving 
the subsequent Ullmann etherification, iodination using N-
iodosuccinimide (NIS) was attempted. Compared to the carbon-
bromine bond the carbon-iodine has a lower bond enthalpy, 
measured experimentally for the aryl halide C6H5X as 84 kcal   
mol-1 and 67 kcal mol-1 for X = ‘Br’ and ‘I’ respectively.[9] 
Therefore, we hypothesised that 3-iodoquinolin-4(1H)-ones 
should show an increased reactivity towards oxidative addition in 
the Ullmann condensation compared to 3-bromoquinolin-4(1H)-
ones.  
Attempts to optimise the alkoxylation of the 3-iodoquinolin-
4(1H)-ones established that temperatures of 120 °C were 
required for an efficient conversion to the product and that using 
more than one equivalent of copper (I) iodide facilitated the 
undesired reductive dehalogenation process. Using a set of 
general conditions methoxylation and ethoxylation of 3-
iodoquinolin-4(1H)-ones 31 – 35 were carried out successfully, 
yielding the waltherione F 3 analogues 36 – 43 (Table 2). 
 
Table 2. Synthesised waltherione F analogues 36 – 49. 
 
 
 
Waltherione analogues 36 – 43 were obtained in variable yields 
and deemed to be of sufficient purity by HRMS, 1H and 13C NMR 
analysis. Yields for methoxylation reactions were in general 
Product R1 and 
R2 
Yield
% 
By-product Yield % 
 
 
 
 
 
 
 
 
 
 
R1 = 
Ethyl 
R2 = 
Methyl 
 
 
79 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
 
 
 
 
 
 
R1 = 
Ethyl 
R2 = 
Ethyl 
 
 
52 
 
 
 
 
 
 
 
 
 
R1 = 
Isopropyl 
R2 = 
Methyl 
 
 
76 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
 
 
 
 
 
 
 
R1 = 
Isopropyl 
R2 = 
Ethyl 
 
 
41 
 
 
 
 
 
 
 
 
R1 = n-
Butyl 
R2 = 
Methyl 
 
 
36 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
13 
 
 
 
 
 
 
 
 
R1 = n-
Butyl 
R2 = 
Ethyl 
 
 
25 
 
 
 
 
 
 
 
 
 
 
R1 = 
Methoxy
methyl 
R2 = 
Methyl 
 
 
8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
20 
 
 
 
 
 
R1 = 
Methoxy   
methyl 
R2 = 
Ethyl 
 
 
12 
 
 
 
 
 
 
 
 
R1 = 
Methyl 
R2 = 
Ethyl 
 
 
49 
 
 
 
 
 
 
 
 
 
 
 
9 
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greater than those for ethoxylation reactions, with ethoxylation 
reactions yielding a greater proportion of the reductive 
dehalogenation by-product. Methoxymethyl analogues 42 and 
43 had significantly lower yields as they were observed to stick 
to the column during purification. 
During the isolation of waltherione F 3 analogues, 3-
dimethylaminequinolin-4(1H)-one species 45 – 49 were 
observed. It is well known that under basic conditions and 
elevated temperatures, such as those employed in the 
alkoxylation of the 3-iodoquinolin-4(1H)-one cores, DMF can be 
hydrolysed to produce dimethylamine which acts as a 
nucleophile in the Ullmann condensation (Scheme 6). [10],[11] 
 
 
Scheme 6. Proposed mechanism for the Ullmann condensation with 
dimethylamine. 
Attempts to synthesise waltherione F analogues in which R2 = i-
Pr and t-Bu using a variety of conditions with potassium tert-
butoxide and sodium isopropoxide were unsuccessful. This 
observation could be due to unfavourable steric interactions.  
A further modification at the 3-postion utilized the penultimate 
compound of the sequence towards Waltherione F 3, 3-bromo-
8-methoxy-2-methyl-5-octylquinolin-4(1H)-one 24, in a 
microwave assisted palladium-catalysed Suzuki cross-coupling 
reaction to afford analogues 50 – 56. Compound 24 was reacted 
with a range of boronic acids, the selection of which was guided 
by the work of Craig, where the aromatic substituents were 
chosen for their varying lipophilic and electronic properties 
(Table 3).[12] 
 
 
 
 
 
Table 3. Synthesis of Waltherione F analogues 50 – 56. 
  
Product R Yield (%) 
50 Phenyl 64 
51 4-Chlorophenyl 55 
52 3-Chlorophenyl 39 
53 4-Methoxyphenyl 57 
54 4-Tolyl 51 
55 4-Cyanophenyl 42 
56 4-Trifluoromethoxybenzyl 47 
 
 
The authors would like to note that after completion of this work, 
a synthesis of waltherione F 3 using an alternative synthetic 
approach has appeared.[13]   
Conclusions 
Waltherione F 3 was synthesised in 5-step reaction sequence. 
One of the key reactions was the formation of 8-methoxy-2-
methyl-5-octylquinolin-4(1H)-one 23 which was achieved within 
6 hours which was an improvement of the 2 week synthesis 
reported in the literature for similar compounds.[14] Analytical 
data for synthetic waltherione F 3 correlated with that of natural 
material from the roots of Waltheria indica as reported by 
Cretton et al,[1] along with first X-ray crystallographic 
confirmation, thus successfully confirming the identity of 
waltherione F 3. 
A library of novel waltherione analogues 36 – 44 with variations 
at 2- and 3-positions were successfully synthesised utilising the 
Conrad-Limpach synthesis and Ullmann condensation. In 
synthesising analogues 36 – 44 the formation of what were later 
identified as 3-dimethylaminequinolin-4(1H)-one analogues 45 – 
49 was observed and successfully isolated from their respective 
reaction mixtures.  
A separate library of analogues 50 – 56 with varying aromatic 
and benzylic substituents at the 3-position was prepared using a 
microwave-assisted Suzuki cross-coupling reaction. 
Work on the antitrypanosomal properties of the waltheriones is 
on-going and will be reported at a later date. 
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Experimental Section 
For detailed experimental procedures, compound data and 
spectra see supplementary information. 
2-Methoxy-5-octylaniline 22 
Heptyltriphenylphosphonium bromide 20 (2.40 g, 5.52 mmol) and 
anhydrous tetrahydrofuran (20 mL) were put in an oven dried 100 
mL round-bottom flask and the mixture was left to cool to 0 °C in an 
ice bath. Potassium tert-butoxide (5.52 mL, 5.52 mmol) was then 
added dropwise to the reaction mixture which changed from 
colourless to a deep orange over a few seconds. After one hour, 4-
methoxy-3-nitrobenzaldehyde 19 (1.00 g, 5.52 mmol) in anhydrous 
tetrahydrofuran (5 mL) was added to the reaction mixture, which 
quickly changed to a dark brown colour. After 4 hours, the reaction 
mixture was extracted with ethyl acetate (20 mL) and washed with 
water (3*10 mL). The organic phase was then dried over magnesium 
sulphate and the solvent was removed under reduced pressure. The 
crude material was purified through flash column chromatography on 
silica gel (20% to 60% ethyl acetate in petroleum ether, Rf = 0.70) to 
afford a mixture of isomers (Z)-21 and (E)-21 as a yellow oil, which 
was subjected to the next step without further characterisation. (0.98 
g, 3.75 mmol, 68% yield). 1-Methoxy-2-nitro-4-(oct-1-en-1-
yl)benzene (Z)/(E)-21  (0.98 g, 3.75 mmol) in methanol (10 mL) was 
run through a hydrogenation reactor at 20 bar and 40 °C with a 
palladium on carbon catalyst for 2 hours. The reaction mixture 
turned from yellow to orange over the course of the reaction. After 
the completion of the reaction, the mixture was concentrated under 
reduced pressure to afford orange oil. Subsequent physicochemical 
analysis confirmed this to be the title compound 22 (0.75 g, 3.20 
mmol, 85% yield). 
1H NMR (500 MHz, Chloroform-d) δ 6.70 (d, J = 8.0 Hz, 1H, ArH), 
6.56 (d, J = 2.0 Hz, 1H, ArH), 6.53 (dd, J = 8.0, 2.0 Hz, 1H, ArH), 
3.82 (s, 3H, OCH3), 3.72 (s, 2H, NH2), 2.47 (t, J = 7.7 Hz, 2H, 
ArCH2R), 1.56 (quint, J = 7.4 Hz, 2H, CH2), 1.36 – 1.22 (m, 10H, 
aliphatic), 0.88 (t, J = 6.8 Hz, 3H, CH3); 13C NMR (126 MHz, 
Chloroform-d) δ 145.7 (C=O), 136.0, 135.9, 118.3, 115.5, 110.6, 
55.8, 35.5, 32.1, 31.8, 29.7, 29.5, 29.4, 22.8, 14.2; MS (LCMS) 
found m/z 236.1 [M + H]+, Rt = 2.46 min; HRMS (ESI) exact mass 
calculated for [C15H26NO] requires m/z 236.2009, 
found m/z 236.2010 [M + H]+; IR (νmax, cm
-1) 3418 (N-H stretch), 
2961 (C-H stretch), 2920 (C-H stretch), 2851 (C-H stretch), 1515 
(C=C bend, aromatic), 1228 (C-O stretch), 1027 (C-N stretch). 
 
8-Methoxy-2-methyl-5-octylquinolin-4(1H)-one 23 
2-Methoxy-5-octylaniline 22 (0.40 g, 1.70 mmol), methyl 
acetoacetate 15 (0.20 g, 1.90 mmol), concentrated hydrochloric acid 
(0.10 mL, 0.02 mmol), anhydrous dichloromethane (30 mL) and 
activated 4Å molecular sieves were put in an oven-dried 100 mL 
round-bottom flask and left to stir under nitrogen atmosphere. The 
reaction mixture was left stirring for 4 hours which then was filtered 
and concentrated under reduced pressure affording a white 
amorphous solid. Diphenyl ether (10 mL) was put into a two-necked 
50 mL round-bottom flask fitted with a Liebig condenser and a 
dropping funnel and the flask was heated to 250 °C. The 
intermediate was dissolved in diphenyl ether (10 mL) and added 
dropwise to the flask. The mixture turned from amber to dark brown 
over the course of the reaction. After 1.5 hours, the reaction mixture 
was cooled to room temperature and purified through flash column 
chromatography on silica gel (0% to 5% methanol in 
dichloromethane, Rf = 0.44) to afford a yellow solid. Subsequent 
physicochemical analysis confirmed this to be the title compound 23 
(0.20 g, 0.68 mmol, 41% yield). 
M.p. 116-119 °C; 1H NMR (500 MHz, DMSO-d6) δ 10.58 (s, 1H, N-H), 
7.05 (d, J = 8.1 Hz, 1H, ArH), 6.85 (d, J = 8.1 Hz, 1H, ArH), 5.82 (s, 
1H, ArH), 3.93 (s, 3H, OCH3), 3.16 (t, J = 7.6 Hz, 2H, ArCH2R), 2.31 
(s, 3H, ArCH3), 1.46 (quint, J = 7.6 Hz, 2H, CH2), 1.31 – 1.16 (m, 
10H, aliphatic), 0.83 (t, J = 6.8 Hz, 3H, CH3); 
13C NMR (126 MHz, 
DMSO-d6) δ 178.6 (C=O), 147.5, 146.2, 134.6, 132.4, 123.5, 122.7, 
110.9, 110.3, 55.9, 34.1, 31.9, 31.2, 29.1, 28.9, 28.7, 22.0, 18.9, 
13.8; MS (LCMS) found m/z 302.1 [M + H]+, Rt = 2.51 min; HRMS 
(ESI) exact mass calculated for [C19H28NO2] requires m/z 302.2515, 
found m/z 302.2516 [M + H]+; IR (νmax, cm
-1) 2919 (C-H stretch), 
2850 (C-H stretch), 1627 (C=O stretch), 1521 (C=C stretch, 
aromatic), 1730 (C-O stretch), 1170 (C-N stretch). 
 
3-Bromo-8-methoxy-2-methyl-5-octylquinolin-4(1H)-one 24 
8-Methoxy-2-methyl-5-octylquinolin-4(1H)-one (0.10 g, 0.31 mmol) 
23 in acetonitrile (8 mL) and N-bromosuccinimide (0.06 g, 0.35 
mmol) in acetonitrile (5 mL) were put in a 25 mL round-bottom flask 
and left to stir at room temperature. Within a few seconds of the 
addition of N-bromosuccinimide, a white precipitate formed in the 
orange reaction mixture. After 2 hours, the reaction reached 
completion and the mixture was washed with water (3*10 mL), 
extracted with dichloromethane (10 mL), dried over magnesium 
sulphate and concentrated under reduced pressure to afford brown 
solid. Subsequent physicochemical analysis confirmed this to be the 
title compound 24 (0.08 g, 0.22 mmol, 71% yield). 
M.p. 129-139 °C; 1H NMR (500 MHz, DMSO-d6) δ 11.06 (s, 1H, N-
H), 7.11 (d, J = 8.1 Hz, 1H, ArH), 6.95 (d, J = 8.1 Hz, 1H, ArH), 3.95 
(s, 3H, OCH3), 3.14 (t, J = 7.6 Hz, 2H, ArCH2R), 2.59 (s, 3H, ArCH3), 
1.46 (quint, J = 7.6 Hz, 2H, CH2), 1.33 – 1.16 (m, 10H, aliphatic), 
0.83 (t, J = 6.6 Hz, 3H, CH3); 
13C NMR (126 MHz, DMSO-d6) δ 172.0 
(C=O), 146.9, 146.1, 134.5, 130.9, 124.7, 121.0, 110.6, 109.1, 56.0, 
34.4, 31.8, 31.2, 29.1, 28.9, 28.7, 22.0, 20.8, 13.8; MS (LCMS) 
found m/z 380.0 [M + H]+, Rt = 3.36 min; HRMS (ESI) exact mass 
calculated for [C19H27BrNO2] requires m/z 380.1220, 
found m/z 380.1227 [M + H]+; IR (νmax, cm
-1) 2921 (C-H stretch), 
2851 (C-H stretch), 1622 (C=O stretch), 1559 (C=C stretch, 
aromatic), 1271 (C-O stretch), 1169 (C-N stretch). 
 
3,8-Dimethoxy-2-methyl-5-octylquinolin-4(1H)-one 3 [1] 
3-Bromo-8-methoxy-2-methyl-5-octylquinolin-4(1H)-one (0.08 g, 0.22 
mmol) 24 in dimethyl formamide (5 mL), sodium methoxide (0.20 
mL, 1.08 mmol) and copper iodide (0.02 g, 0.11 mmol) were put in a 
50 mL round-bottom flask. The mixture was heated to 120 °C and 
then was left to stir and reflux for 2 hours. After reaction completion, 
the reaction mixture was filtered through a sintered funnel and the 
filtrate was concentrated under reduced pressure which afforded a 
yellow amorphous solid. The product was purified through flash 
column chromatography on silica gel (0% to 7% methanol in 
dichloromethane) to afford pale yellow solid. Subsequent 
physicochemical analysis confirmed this to be the title compound 3 
(0.05 g, 0.14 mmol, 64% yield). 
M.p. 108-110 °C; 1H NMR (500 MHz, Methanol-d4) δ 6.98 (d, J = 8.1 
Hz, 1H, ArH), 6.89 (d, J = 8.1 Hz, 1H, ArH), 3.97 (s, 3H, OCH3), 3.77 
(s, 3H, OCH3), 3.25 (d, J = 7.7 Hz, 2H, ArCH2R), 2.46 (s, 3H, 
ArCH3), 1.58 (quint, J = 7.7 Hz, 2H, CH2), 1.38 (p, J = 14.6, 6.8 Hz, 
2H, CH2), 1.34 – 1.21 (m, 8H, aliphatic), 0.87 (t, J = 6.8 Hz, 3H, 
CH3); 
13C NMR (126 MHz, Methanol-d4) δ 175.9 (C=O), 147.8, 
143.2, 142.6, 136.8, 132.4, 125.3, 125.1, 110.6, 60.2, 56.6, 36.3, 
33.6, 33.0, 30.9, 30.8, 30.5, 23.7, 14.4, 14.1; MS (LCMS) found 
m/z 332.1 [M + H]+, Rt = 2.77 min; HRMS (ESI) exact mass 
calculated for [C20H30NO3] requires m/z 332.2220, 
found m/z 332.2223 [M + H]+; IR (νmax, cm
-1) 2920 (C-H stretch), 
2850 (C-H stretch), 1629 (C=O stretch), 1518 (C=C stretch, 
aromatic), 1260 (C-O stretch), 1025 (C-N stretch). 
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2-Substituted quinolin-4(1H)-one derivatives 25 – 28 
1. To an oven dried round-bottom flask anhydrous dichloromethane, 
2-methoxy-5-octylaniline 22 (1 equiv) and activated 4Å molecular 
sieves were added and left stirring under a nitrogen atmosphere. 
The β-Keto ester (1 equiv) was added dropwise to the stirred mixture 
before addition of 37% hydrochloric acid (0.01 equiv) and left stirring 
until completion for the indicated solvent, time and temperature. The 
reaction mixture was filtered through celite and the solvent removed 
under reduced pressure, yielding an intermediate. 2. Diphenyl ether 
(10 mL) was added to a three-necked round-bottom flask and fitted 
with a reflux condenser and dropping funnel before heating to 
250 °C. The intermediate was added dropwise to the flask and the 
reaction left stirring for the indicated time, taking on a dark brown 
colour. The crude reaction mixture was left to cool to room 
temperature before purification using flash column chromatography 
on silica gel (100% dichloromethane followed by 0% - 7% methanol 
in dichloromethane), yielding the desired 2-substituted quinolin-
4(1H)-ones 25 – 28. 
 
3-Iodo-quinolin-4(1H)-one derivatives 31 – 35 
To a 5 mL microwave vial, the quinolin-4(1H)-one core (1.0 equiv) 
was added and suspended in acetonitrile (5 mL) and cooled to 0 °C 
in an ice bath. To the stirred suspension, N-iodosuccinimide (1.1 
equiv) was added and the reaction was brought to room temperature 
and left stirring for 1 hour. The solvent was removed under reduced 
pressure and the resulting solid dissolved in a mixture of 
dichloromethane (5 mL) and water (5 mL). The mixture was 
sonicated, filtered through a phase separation cartridge, and the 
organic phase was concentrated under reduced pressure, yielding 
the desired 3-iodoquinolin-4(1H)-ones 31 – 35. 
 
3-Alkoxy-quinolin-4(1H)-one derivatives 36 – 44 
In a 2 mL microwave vial, the 3-iodoquinolin-4(1H)-one core (1 
equiv) and copper (I) iodide (1 equiv) were suspended in N,N-
dimethylformamide (1 mL) before addition of the sodium alkoxide 
solution (5 equiv). The vial was heated in a microwave at 120 °C for 
the indicated time before reaching completion. The reaction mixture 
was filtered through a nylon filter and the solvent removed under 
reduced pressure. The crude solid was purified using a preparative 
HPLC system before filtering through a silica-supported carbonate 
cartridge, yielding the desired 3-methoxyquinolin-4(1H)-one and 3-
ethoxyquinolin-4(1H)-one derivatives 36 – 44. 
 
3-Aryl- and 3-benzyl-quinolin-4(1H)-one derivatives 50 – 56 
A suspension of 3-bromo-8-methoxy-2-methyl-5-octylquinolin-4(1H)-
one 24 (1 equiv), boronic acid (1.1 equiv) and 
bis(triphenylphosphine)palladium chloride (0.02 equiv) in acetonitrile 
(1 mL) was treated with aqueous 2M sodium carbonate (1 mL) and 
heated in a microwave at 100 °C for the indicated time before 
reaching completion. The reaction mixture was filtered through a 
nylon filter and the solvent removed under reduced pressure. The 
crude solid was purified using a preparative HPLC system before 
filtering through a silica-supported carbonate cartridge, yielding the 
desired 3-aryl- and 3-benzyl-quinolin-4(1H)-one derivatives 50 – 56. 
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